| Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and … VG Athyros, K Tziomalos, TD Gossios, T Griva, P Anagnostis, K Kargiotis, ... The Lancet 376 (9756), 1916-1922, 2010 | 892 | 2010 |
| Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence E Christaki, M Marcou, A Tofarides Journal of molecular evolution 88 (1), 26-40, 2020 | 598 | 2020 |
| New technologies in predicting, preventing and controlling emerging infectious diseases E Christaki Virulence 6 (6), 558-565, 2015 | 223 | 2015 |
| The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host E Christaki, EJ Giamarellos-Bourboulis Virulence 5 (1), 57-65, 2014 | 103 | 2014 |
| The beginning of personalized medicine in sepsis: small steps to a bright future E Christaki, EJ Giamarellos‐Bourboulis Clinical genetics 86 (1), 56-61, 2014 | 84 | 2014 |
| The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection M Choi, N Hegerle, J Nkeze, S Sen, S Jamindar, S Nasrin, S Sen, ... Frontiers in microbiology 11, 1249, 2020 | 74 | 2020 |
| Immunomodulatory therapy for sepsis: an update E Christaki, P Anyfanti, SM Opal Expert review of anti-infective therapy 9 (11), 1013-1033, 2011 | 71 | 2011 |
| A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia E Christaki, SM Opal, JC Keith Jr, N Kessimian, JE Palardy, NA Parejo, ... Shock 35 (5), 492-498, 2011 | 69 | 2011 |
| Is the mortality rate for septic shock really decreasing? E Christaki, SM Opal Current opinion in critical care 14 (5), 580-586, 2008 | 67 | 2008 |
| Estrogen receptor β agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study E Christaki, SM Opal, JC Keith Jr, N Kessinian, JE Palardy, NA Parejo, ... The Journal of infectious diseases 201 (8), 1250-1257, 2010 | 53 | 2010 |
| NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon‐γ Production E Christaki, E Diza, EJ Giamarellos-Bourboulis, N Papadopoulou, ... Journal of immunology research 2015 (1), 532717, 2015 | 41 | 2015 |
| ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery E Righi, NT Mutters, X Guirao, MD Del Toro, C Eckmann, AW Friedrich, ... Clinical Microbiology and Infection 29 (4), 463-479, 2023 | 35 | 2023 |
| Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of … E Christaki, N Lazaridis, SM Opal Current opinion in infectious diseases 25 (3), 304-311, 2012 | 35 | 2012 |
| Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection S Nasrin, N Hegerle, S Sen, J Nkeze, S Sen, J Permala-Booth, M Choi, ... BMC microbiology 22 (1), 13, 2022 | 34 | 2022 |
| Specific Antibody to Cryptococcus neoformans Glucurunoxylomannan Antagonizes Antifungal Drug Action against Cryptococcal Biofilms In Vitro LR Martinez, E Christaki, A Casadevall The Journal of infectious diseases 194 (2), 261-266, 2006 | 34 | 2006 |
| The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study V G Athyros, K Tziomalos, N Katsiki, T D Gossios, O Giouleme, ... Current vascular pharmacology 11 (5), 779-784, 2013 | 32 | 2013 |
| The impact of climate change on cholera: a review on the global status and future challenges E Christaki, P Dimitriou, K Pantavou, GK Nikolopoulos Atmosphere 11 (5), 449, 2020 | 31 | 2020 |
| Influenza virus—host co-evolution. A predator-prey relationship? K Voskarides, E Christaki, GK Nikolopoulos Frontiers in immunology 9, 2017, 2018 | 30 | 2018 |
| Extensive testing and public health interventions for the control of COVID-19 in the Republic of Cyprus between march and may 2020 A Quattrocchi, I Mamais, C Tsioutis, E Christaki, C Constantinou, M Koliou, ... Journal of clinical medicine 9 (11), 3598, 2020 | 27 | 2020 |
| Gut microbiota modulation and prevention of dysbiosis as an alternative approach to antimicrobial resistance: a narrative review R Matzaras, A Nikopoulou, E Protonotariou, E Christaki The Yale Journal of Biology and Medicine 95 (4), 479, 2022 | 25 | 2022 |
